Abstract |
We report the results of umbilical cord blood transplantation (UCBT) performed in 88 patients with primary immunodeficiency (PID) between 1998 and 2008 in Japan; severe combined immunodeficiency (SCID, n = 40), Wiskott-Aldrich syndrome (WAS, n = 23), chronic granulomatous disease (n = 7), severe congenital neutropaenia (SCN, n = 5) and other immunodeficiencies (n = 13). Five-year overall survival (5-year OS) for all patients was 69% [95% confidence interval (CI), 57-78%], and was 71% and 82% for SCID and WAS, respectively. The main cause of death before day 100 was infection (17/19), while that after day 100 was graft-versus-host disease (GVHD) (5/7). Using multivariate analyses, pre-transplant infection, no conditioning, ≥ 2 human leucocyte antigen (HLA) mismatches or diagnosis other than SCID, SCN or WAS were all associated with poor prognosis. Reduced-intensity conditioning was associated with decreased overall mortality compared with myeloablative therapy. The cumulative incidence of grade 2-4 acute GVHD at day 100 was 28% (95% CI, 19-38%), and that of chronic GVHD at day 180 was 13% (95% CI, 7-23%). We conclude that UCBT should be considered for PID patients without an HLA-matched sibling. The control of pre-transplant infection and selection of HLA-matched donors will lead to a better outcome.
|
Authors | Tomohiro Morio, Yoshiko Atsuta, Daisuke Tomizawa, Tokiko Nagamura-Inoue, Koji Kato, Tadashi Ariga, Keisei Kawa, Kazutoshi Koike, Hisamichi Tauchi, Michiko Kajiwara, Toshiro Hara, Shunichi Kato, Japanese Cord Blood Bank Network |
Journal | British journal of haematology
(Br J Haematol)
Vol. 154
Issue 3
Pg. 363-72
(Aug 2011)
ISSN: 1365-2141 [Electronic] England |
PMID | 21569009
(Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2011 Blackwell Publishing Ltd. |
Topics |
- Adolescent
- Child
- Child, Preschool
- Cord Blood Stem Cell Transplantation
(adverse effects, methods)
- Epidemiologic Methods
- Graft Survival
- Graft vs Host Disease
(etiology)
- Histocompatibility
- Humans
- Immunologic Deficiency Syndromes
(therapy)
- Infant
- Infant, Newborn
- Opportunistic Infections
(etiology)
- Severe Combined Immunodeficiency
(therapy)
- Transplantation Conditioning
(methods)
- Treatment Outcome
- Wiskott-Aldrich Syndrome
(therapy)
- Young Adult
|